[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 10, Issue 5 (9-2005) ::
3 2005, 10(5): 613-619 Back to browse issues page
Topical Cyclosporine A 2% in Management of Endothelial Corneal Allograft Rejection
M Nejabat MD , J Khoshghadam MD, A Katbab MD, H Khoshniat MD, HR Jahadi MD, H Movahedan MD, R Salouti MD
Abstract:   (8092 Views)

Purpose: To determine whether adding 2% topical cyclosporine (CSA) to local and systemic steroids in treatment of endothelial corneal allograft rejection improves the outcome.

Methods: A prospective randomized treatment trial was carried out on 40 consecutive corneal graft recipients, presenting with the first episode of endothelial graft rejection in two groups. Group one (20 patients) received topical steroid eye drops and oral prednisolone (1 mg/kg). Group two (20 patients) received the same topical and systemic therapy plus 2% cyclosporine eye drops. The patients were followed up for three months and their clinical outcomes were evaluated by the rates and time for reversal of rejection.

Results: In group one, 14 (70%) cases had total reversal of graft rejection episode  which started within a mean period of three days, but in the CSA group, it occurred in 18 (90%) cases which started within a mean period of 1.5 days (P=0.21). Among patients who sought treatment early (< 6 days), survival rates were 85% and 100%, respectively (P=0.2). In high risk patients, the rejection reversal rate was 66% in CSA group and 25% in the control group (P=0.5).

Conclusion: Addition of 2% CSA eye drop to topical and systemic steroids may improve the rates of graft rejection reversal. It may also decrease the interval between initiation of treatment and improvement of clinical signs.

Keywords: cyclosporine A, penetrating keratoplasty, graft rejection
Full-Text [PDF 240 kb]   (1534 Downloads)    
Type of Study: Research | Subject: General
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nejabat M, Khoshghadam J, Katbab A, Khoshniat H, Jahadi H, Movahedan H et al . Topical Cyclosporine A 2% in Management of Endothelial Corneal Allograft Rejection. 3. 2005; 10 (5) :613-619
URL: http://binajournal.org/article-1-694-en.html

Volume 10, Issue 5 (9-2005) Back to browse issues page
مجله چشم‌پزشکی بینا Bina Journal of Ophthalmology
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4319